Over the last two years, as the company's share price mainly soared, Questcor insiders have sold more than $100 million of stock. THE story of Questcor's wonder drug begins in Rochester, Minn. This merger is a cash plus stock reorganization. For tax purposes this is treated as a sale of Questcor, where the proceeds are then used to purchase Mallinckrodt. All the information below is from the information available in the S-4 or 424B3 filed with the SEC. 1. Sell Transaction. The total merger consideration is $92.70 per Questcor share. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Statements sources . The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission () through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR).The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. I believe QCOR should be trading at about $75 a share, which would be 13 times expected earnings for 2014. That's a conservative estimate. Until late last week, the market seemed to agree with me that QCOR is deeply undervalued. The stock gained 180% from its 2012 close to its 2013 high before selling off last week. Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Search Result for Stock QCOR. GuruFocus.com - Stock Picks & Market Insight of Investment Gurus
The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) shares, was initiated concerning whether the takeover of Questcor Pharmaceuticals Inc by Mallinckrodt plc for a value of approximately $86.10 per share is unfair to NASDAQ:QCOR stockholders.
Under the terms of the agreement, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) shareholders will receive $30 per share in cash plus .897 shares of Mallinckrodt PLC (NYSE:MNK) for every Questcor share they hold. This values the deal at about $86.10 a share, which is a 27% premium to Questcor's closing price on Friday. QCOR is rated 1.50 on average by 2 ValueForum.com member(s) [ on a scale of (Strong Buy) 1.00 - 5.00 (Strong Sell) ] in the stock ratings area. The latest rating update was made on Oct. 27 2013, 02:36 AM ET. As a private members-only community, the QCOR message board discussions and further stock rating information, including commentary by the 2 member(s) entering the ratings, is available to If you acquired the common stock of Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) between April 26, 2011 and September 21, 2012 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights. Boston, MA 04/07/2014 (wallstreetpr) - Ireland's Mallinckrodt has announced it his inline to complete the acquisition of Questcor Pharmaceuticals Inc. (NASDAQ:QCOR), in a stock and cash deal valued at $5.2 billion.Questcor is a biopharmaceutical company specialized in the development of treatments for serious medical conditions. Don Bailey Sparked Questcor's Dramatic Rise Licensing. Questcor's stock reflects the Bailey bulge, marching 4,000% since late 2007. Bailey was born in Pittsburgh in 1946. At 17, he became a The $5.6 billion acquisition of Questcor Pharmaceuticals by specialty drugmaker Mallinckrodt started the week off with a big bang. The three major U.S. stock indexes opened lower this morning Company: Questcor Pharmaceuticals, Inc. Buyback: QCOR buyback: Shares Announced Repurchased: 500000: Buyback Details: The Company also announced today that it made open market purchases during the fourth quarter of 2013 of approximately 500,000 shares of Questcor common stock through December 10, 2013.
InvestorGuide.com is the leading online guide to investing, with thousands of categorized links to financial and investing news, research, tools, and other resources.
2014: QUESTCOR PHARMACEUTICALS: Pre-Market Pulse on Health Care Stocks -- Research on Team Health Holdings, Antares Pharma, Illumina, and Questcor Pharma It will also leave welts on the investors who shorted an aggregate 17.5 million shares of Questcor, as of last month, which equaled about 38% of the stock's free-trading "float" and five days Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. QCR Holdings, Inc. Common Stock (QCRH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The requested symbol was not found in our database. Try searching for some other symbol on Yahoo Finance. (QCOR) YHD - YHD Delayed Price. Currency in USD. Add to watchlist. At close: 6:07PM EDT. Questcor Pharmaceuticals, Inc. (Questcor) markets H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS), and the treatment of nephrotic syndrome. Quality of Care and Outcomes Research 2020 Scientific Sessions will take place May 15-16 in Reston, Virginia as scheduled.. Your safety is our number one priority. There will be numerous hand sanitizer stations throughout the conference at the Hyatt Regency Reston, along with self-care tips from the CDC available throughout the meeting.
ARIA: Get the latest Ariad Pharmaceuticals stock price and detailed information including ARIA news, historical charts and realtime prices.
The 11 Best ETFs to Buy for Portfolio Protection. The stock market took a gut punch recently as a number of on-again, off-again headwinds started to blow at the same time. WILMINGTON, Del., April 28, 2014 /PRNewswire/ -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders Got a stock you want Dan to look at? Just ask. Receive video analyis of stocks as they make key moves throughout the day; Access to over 68,200 stock analysis videos; Access an ever expanding library (140) of educational videos that will save you time and make you money Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has faced the affects of bad press more than once in the past. The stock lost more than half of its value last year, after reports about its questionable A year by year calculation of the yearly returns of Questcor Pharmaceuticals, Inc. using the actual trading prices QCOR stock was at during each respective year. All stock splits for QCOR have also been listed. Questcor Pharmaceuticals Inc. (Nasdaq: QCOR) shares surged some 30% in premarket trading Monday after announcing it has agreed to be acquired by Mallinckrodt PLC (NYSE: MNK) in a $5.6 billion cash
(MM) (QCOR) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
WILMINGTON, Del., April 28, 2014 /PRNewswire/ -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders
Therefore, there should be a little, where no threat of a substitutable generic product from these previously approved discontinued products. Many of the old products including the Watson Generic appear to have used an immediate release powder version of pituitary extract, not Questcor's long-acting Acthar Gel. Questcor Pharmaceuticals develops prescription medications primarily for central nervous system disorders, including epilepsy and multiple sclerosis. In addition to maintaining and expanding its own drug portfolio, Questor seeks opportunities to aquire, partner with, and license products from its competitors. Stock options are a form of compensation in which employees are given the opportunity to purchase shares of the company stock at a certain price. Questcor Pharmaceuticals, Inc 401(k) / ERISA Legal Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Become a member for free. Sign up. Sign up Mallinckrodt bought Questcor for about $5.8 billion in 2014. The False Claims Act lets whistleblowers sue on behalf of the government, and share in recoveries. Mallinckrodt's whistleblower, Minnesota resident James Landolt, sued the company in September 2018. In afternoon trading, Mallinckrodt shares were down 68 cents, or 16.1%, at $3.54.